In particular, dovitinib-treated glioblastoma (GB) primary cells and cell lines exhibited downregulation of key base excision repair (BER) factors and O6-methylguanine-DNA-methyltransferase (MGMT), which play crucial roles in repairing temozolomide (TMZ)-induced alkylating DNA damage. Here, MGMT is linked to glioblastoma.